Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

January AI enters Medicare App Library, reaches 69m+ patients

The Centers for Medicare & Medicaid Services (CMS) is launching a Medicare App Library designed to simplify access to health data for beneficiaries, with January AI as a key partner. This initiative aims to empower over 69 million Medicare recipients by providing a centralized platform where they can connect with vetted health applications that translate complex health data into actionable insights. January AI’s platform organizes various health information streams—clinical records, lifestyle habits, and nutrition—into a coherent picture, focusing on practical questions like, “What should I do differently today?” This approach is particularly valuable for managing chronic conditions, such as diabetes, by offering predictive insights into how dietary choices may affect blood sugar levels.

The significance of this development lies in its potential to shift the healthcare paradigm toward patient-controlled care. Historically, health data has been siloed within systems that patients rarely engage with directly. The CMS App Library represents a crucial step in democratizing access to health information, allowing users to choose which tools to connect with and how to utilize their data. This model not only enhances patient engagement but also encourages proactive health management, particularly among older adults who face the highest burden of chronic diseases. January AI’s prior success in virtual glucose monitoring, with over 200,000 users reporting improved health outcomes, underscores the therapeutic potential of this approach.

The key takeaway for longevity science is the transition from reactive healthcare to a model centered on continuous awareness and informed decision-making. This shift is pivotal in promoting healthspan alongside lifespan, as it emphasizes the importance of daily choices in managing health. The integration of personalized, data-driven tools into the lives of older adults signals a significant advancement in the infrastructure necessary for enhancing longevity, making the concept of aging well more tangible and actionable in everyday life.

Source: longevity.technology